EUR/USD
1.19153
0.023%
Gold
5031.95
-0.518%
Oil
64.069
-0.325%
USD/JPY
155.270
-0.395%
GBP/USD
1.36937
-0.014%
GBP/JPY
212.628
-0.395%
Real-time News
On February 10th, Bank of America Securities issued a report stating that Zijin Mining (02899.HK) has raised its production guidance for 2026-2028. Gold production is expected to reach 130-140 tons in 2028, up from the previous guidance of 100-110 tons; the CAGR (compound annual growth rate) between 2025 and 2028 is 13%-16%. Meanwhile, the company guides copper production to reach 1.5 million-1.6 million tons in 2028, representing a CAGR of 11%-14% between 2025 and 2028. The company has also raised its 2028 lithium production guidance to 270,000-320,000 tons, up from the previous 250,000-300,000 tons, representing a CAGR of 121%-134% between 2025 and 2028. The bank reiterated its view that Zijin Mining is its top pick and maintained its buy rating, with target prices of HK$50 for H-shares and RMB45 for A-shares. The bank believes that the company has strong long-term production growth, strict cost control, and reasonable valuation, in addition to its positive outlook on gold and copper prices.On February 10th, Alibaba DAMO Academy released RynnBrain, a basic model for embodied intelligence, and open-sourced seven full-series models, including 30BMoE.On February 10th, according to Tianyancha business information, Guangxi Guangtou Robotics Industry Co., Ltd. was recently established. The legal representative is Chen Chen, and the registered capital is 500 million RMB. Its business scope includes industrial robot manufacturing, industrial robot sales, special-operation robot manufacturing, intelligent robot sales, supply chain management services, software development, artificial intelligence application software development, artificial intelligence basic software development, artificial intelligence public data platform, and satellite communication services. Shareholder information shows that the company is wholly owned by Guangxi Investment Group Liuzhou Digital Intelligence Innovation Co., Ltd.Hong Kong-listed biopharmaceutical stocks rebounded, with Yiming Onco (01541.HK) rising over 7%, Antengene (06996.HK) rising over 6%, Connoya (02162.HK) and Ascletis Pharma (01672.HK) both rising over 5%, and Laikai Pharma (02105.HK) and others following suit.Guotou Silver LOF opened with a drop of over 4%, reaching 3.21 yuan.
